O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-15.63%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.36B
AUM Growth
+$5.36B
(-35%)
Cap. Flow
-$1.44B
Cap. Flow
% of AUM
-26.93%
Top 10 Holdings %
Top 10 Hldgs %
37.64%
Holding
161
New
13
Increased
16
Reduced
46
Closed
30
Top Buys
| 1 |
THOR
Synthorx, Inc. Common Stock
THOR
|
$92.4M |
| 2 |
LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
|
$67.3M |
| 3 |
Guardant Health
GH
|
$57.7M |
| 4 |
CVS Health
CVS
|
$52M |
| 5 |
CELG
Celgene Corp
CELG
|
$50.8M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$149M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$81.2M |
| 3 |
Edwards Lifesciences
EW
|
$80.4M |
| 4 |
Merck
MRK
|
$80.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
$79M |
Sector Composition
| 1 | Healthcare | 96% |
| 2 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arvinas
ARVN
$568M
| $34.4M | 0.64% | 2,678,810 +32,945 | +1% | +$423K |
|
|
OBSV
52
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $33M | 0.61% | 2,605,531 | – | – |
|
53
Abbott
ABT
$231B
| $32.4M | 0.6% | 448,400 +54,300 | +14% | +$3.93M |
|
|
AERI
54
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $31.5M | 0.58% | 872,100 -347,730 | -29% | -$12.6M |
|
|
VRAY
55
DELISTED
ViewRay, Inc.
VRAY
| $31.3M | 0.58% | 5,149,019 -587,248 | -10% | -$3.56M |
|
56
Ironwood Pharmaceuticals
IRWD
$214M
| $29.8M | 0.55% | 2,878,000 -51,250 | -2% | -$531K |
|
57
Gilead Sciences
GILD
$140B
| $27.8M | 0.51% | 443,800 +79,200 | +22% | +$4.95M |
|
58
DaVita
DVA
$9.85B
| $27.5M | 0.51% | 534,000 -911,700 | -63% | -$46.9M |
|
|
59
Bristol-Myers Squibb
BMY
$96B
| $26.3M | 0.49% | 505,900 -1,519,900 | -75% | -$79M |
|
60
Pfizer
PFE
$141B
| $26.3M | 0.49% | 602,200 -66,500 | -10% | -$2.9M |
|
61
Rhythm Pharmaceuticals
RYTM
$6.85B
| $25M | 0.46% | 928,500 -112,853 | -11% | -$3.03M |
|
62
Amgen
AMGN
$155B
| $23.8M | 0.44% | 122,100 -29,500 | -19% | -$5.74M |
|
63
ProQR Therapeutics
PRQR
$237M
| $22.7M | 0.42% | 1,437,731 -600,144 | -29% | -$9.47M |
|
64
Assembly Biosciences
ASMB
$190M
| $22.5M | 0.42% | 996,123 -237,248 | -19% | -$5.37M |
|
65
Corvus Pharmaceuticals
CRVS
$428M
| $21.9M | 0.41% | 5,967,584 | – | – |
|
66
SI-BONE Inc
SIBN
$719M
| $20.6M | 0.38% | +985,368 | New | +$20.6M |
|
67
Stryker
SYK
$150B
| $20.4M | 0.38% | 130,200 | – | – |
|
|
SPPI
68
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $19.8M | 0.37% | 2,265,500 | – | – |
|
|
SVA
69
DELISTED
Sinovac Biotech, Ltd
SVA
| $19.7M | 0.36% | 2,839,500 | – | – |
|
|
FOMX
70
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $18.7M | 0.34% | 5,195,330 | – | – |
|
71
KALA BIO
KALA
$78.8M
| $16.9M | 0.31% | 3,447,840 | – | – |
|
72
DexCom
DXCM
$29.5B
| $16.6M | 0.31% | +138,700 | New | +$16.6M |
|
|
MYOK
73
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $16.4M | 0.3% | +335,100 | New | +$16.4M |
|
74
Spyre Therapeutics
SYRE
$996M
| $16.2M | 0.3% | 2,165,524 | – | – |
|
75
Novo Nordisk
NVO
$251B
| $15.2M | 0.28% | 330,000 | – | – |
|